RBF Capital’s Fresh Tracks Therapeutics, Inc. Common Stock FRTX Stock Holding History

RBF Capital’s Portfolio FRTX Stock Details FRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-42	Closed	-$11K	–	402
2019 Q2	$11K	Hold	42	–	–	﹤0.01%	394
2019 Q1	$16K	Hold	42	–	–	﹤0.01%	387
2018 Q4	$16K	Hold	42	–	–	﹤0.01%	407
2018 Q3	$18K	Hold	42	–	–	﹤0.01%	409
2018 Q2	$15K	Hold	42	–	–	﹤0.01%	394
2018 Q1	$19K	Hold	42	–	–	﹤0.01%	376
2017 Q4	$24K	Hold	42	–	–	﹤0.01%	376
2017 Q3	$34K	Hold	42	–	–	﹤0.01%	360
2017 Q2	$36K	Hold	42	–	–	﹤0.01%	354
2017 Q1	$30K	Hold	42	–	–	﹤0.01%	362
2016 Q4	$30K	Buy	+42	New	+$34.1K	﹤0.01%	368

Other funds holding FRTX

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

NFG

Next Financial Group Houston, Texas $1.52B AUM 20.14% 1-Year Est. Return

SPIA

Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

RBF Capital's FRTX Position: Q3 2019 in Review

RBF Capital sold out of Fresh Tracks Therapeutics, Inc. Common Stock (FRTX) in Q3 2019, closing a stake of 42 shares — an estimated $11K sold.

RBF Capital first reported a position in FRTX in Q4 2016 and held it in 11 quarters. The position peaked at $36K in Q2 2017. 17 funds tracked by Wall St. Rank hold FRTX as of Q3 2019.

RBF Capital reported no remaining Fresh Tracks Therapeutics, Inc. Common Stock position as of Q3 2019 after selling out during the quarter.
RBF Capital sold 42 Fresh Tracks Therapeutics, Inc. Common Stock shares in Q3 2019, an estimated $11K.
RBF Capital first reported a position in Fresh Tracks Therapeutics, Inc. Common Stock in Q4 2016 and held it in 11 quarters.
RBF Capital's Fresh Tracks Therapeutics, Inc. Common Stock position peaked at $36K in Q2 2017.
17 funds tracked by Wall St. Rank held Fresh Tracks Therapeutics, Inc. Common Stock as of Q3 2019.

Based on RBF Capital's 13F filing for Q3 2019, filed 13 Nov 2019.